The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

Before the FDA approved AstraZeneca’s Fasenra, Nucala was the only therapy for treating eosinophilic granulomatosis with ...

GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...

With the expiration of a contract to produce antibiotic medicines for Sandoz, GSK will shutter a 75-year-old manufacturing ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

Pharmaceutical groups GSK and AstraZeneca are vying to be the first to finally upgrade their popular inhalers which deliver a life-saving puff of medicine but damage the planet.

The British pharma said its shot didn’t meet the efficacy goals of a Phase 2 study. Elsewhere, Zealand reported more obesity drug data and Lilly appointed a company veteran as its new CFO.

Depemokimab was shown to reduce exacerbations in patients with severe asthma. The proportions of adverse events of ...

Understanding those ingredients, will impart you the essentials of the pharmaceutical market in Egypt. GSK has understood the game of access in Egypt earlier than other companies. By buying two ...

Without revealing specific details, GSK announced that it is terminating the development of its investigational herpes ...